Cardinal Health, Inc. (NYSE:CAH - Get Free Report) CEO Jason M. Hollar sold 107,705 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the sale, the chief executive officer owned 235,901 shares in the company, valued at $35,125,658.90. This trade represents a 31.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Cardinal Health Trading Down 2.3%
Shares of NYSE CAH traded down $3.5270 during trading hours on Friday, reaching $148.0430. The stock had a trading volume of 2,685,985 shares, compared to its average volume of 2,600,685. The firm has a market cap of $35.35 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 1.25 and a beta of 0.67. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The firm has a 50-day moving average of $159.02 and a 200-day moving average of $145.58.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm's revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's dividend payout ratio is currently 31.63%.
Institutional Trading of Cardinal Health
Several hedge funds have recently modified their holdings of the business. Norges Bank acquired a new position in Cardinal Health during the second quarter worth $584,420,000. Wellington Management Group LLP boosted its position in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. Castlekeep Investment Advisors LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth $141,963,000. JPMorgan Chase & Co. increased its holdings in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Cardinal Health by 17,589.1% in the 1st quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock valued at $132,940,000 after purchasing an additional 959,486 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts have commented on CAH shares. Leerink Partners dropped their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Wells Fargo & Company reaffirmed an "overweight" rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Bank of America upped their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research note on Tuesday, June 10th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average target price of $163.20.
Check Out Our Latest Analysis on CAH
About Cardinal Health
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access